Fluvastatin 40 mg Tablet PCD Franchise in Mumbai

Lipid-Lowering Medicine Supplier in Delhi

Hyperlipidemia Treatment Tablet Distributor in Ahmedabad

Cardiology Care Pharma Franchise in Chennai

Fluvastatin 40 mg Stockist in Hyderabad
Lipid-Lowering Tablet Export & Manufacturing in Pune

Home/Products /fluvastatin-40mg-tablet

Flubot 40 Tablet

Composition : Fluvastatin (40mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Flubot 40 Tablet contains Fluvastatin 40 mg, an HMG-CoA reductase inhibitor used for the management of hypercholesterolemia and hyperlipidemia. It works by reducing LDL cholesterol and triglycerides while modestly raising HDL cholesterol, improving overall cardiovascular health.

Belonging to the cardiology and lipid management segment, Flubot 40 Tablet is commonly prescribed for patients with high cholesterol, mixed dyslipidemia, and those at risk of cardiovascular events. Its consistent efficacy ensures high patient compliance and repeat prescriptions.

Fluvastatin aids in preventing plaque formation in arteries, thereby reducing the risk of atherosclerosis, heart attacks, and strokes, making it essential in long-term cardiovascular care.

For PCD pharma franchise partners, distributors, exporters, and third-party manufacturing clients, Flubot 40 Tablet provides a profitable B2B opportunity, with steady demand across hospitals, clinics, and retail pharmacies in India.


Read More

About the Product

Flubot 40 Tablet contains Fluvastatin 40 mg, an HMG-CoA reductase inhibitor used for the management of hypercholesterolemia and hyperlipidemia. It works by reducing LDL cholesterol and triglycerides while modestly raising HDL cholesterol, improving overall cardiovascular health.

Belonging to the cardiology and lipid management segment, Flubot 40 Tablet is commonly prescribed for patients with high cholesterol, mixed dyslipidemia, and those at risk of cardiovascular events. Its consistent efficacy ensures high patient compliance and repeat prescriptions.

Fluvastatin aids in preventing plaque formation in arteries, thereby reducing the risk of atherosclerosis, heart attacks, and strokes, making it essential in long-term cardiovascular care.

For PCD pharma franchise partners, distributors, exporters, and third-party manufacturing clients, Flubot 40 Tablet provides a profitable B2B opportunity, with steady demand across hospitals, clinics, and retail pharmacies in India.


Common side effects may include headache, nausea, mild gastrointestinal discomfort, and muscle aches. Rarely, it may cause severe muscle problems (myopathy/rhabdomyolysis), liver dysfunction, or allergic reactions. Seek medical attention if you experience persistent muscle pain, yellowing of eyes, or dark urine.

Flubot 40 Tablet is indicated for the treatment of hypercholesterolemia and mixed dyslipidemia. It helps decrease elevated LDL cholesterol and triglycerides while increasing HDL cholesterol, reducing the risk of heart attack, stroke, and atherosclerosis.

Take Flubot 40 Tablet exactly as prescribed, preferably at bedtime for optimal effect. Avoid consuming excessive alcohol. Regular monitoring of liver function and kidney function is recommended during therapy. Inform your doctor if you have liver disease or a history of muscle disorders.

Store Flubot 40 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation